The Southern California Biomedical Council (SoCalBio) has elected life
sciences investor Joseph (Joe) A. Boystak to its board of directors. The
election was held during SoCalBio's board meeting on January 23rd.
"Joe brings decades of experience in corporate finance and life sciences
investing, and he knows how to help guide SoCalBio's efforts to improve
how local emerging companies access sources of funding," said Robert
Greenberg, MD, PhD, SoCalBio Board Chairman and President & CEO of
Sylmar-based Second Sight Products Corporation.
Upon his election, Mr. Boystak said, "I am delighted to join the
SoCalBio board and to help the organization expand its role as an
advocate and conduit for everything necessary to accelerate growth of
the L.A. region's biomedical industry. I look forward to working with
SoCalBio to improve access to capital resources, including novel and
innovative funding opportunities."
Mr. Boystak currently serves as Partner at New York and Santa
Monica-based Poliwogg Holdings, Inc. (www.poliwogg.com)
- an innovative financial firm that provides new pathways for accredited
investors to invest in early stage health and life science companies.
He also serves as President and CEO of Brightwaters Capital, LLC, an
investmentfirm based in Los Angeles that focuses on life sciences,
medical devices, diagnostics, health care and materials science. He is
also Managing Director and CEO of Hudson | Brightwaters (a division of
Hudson Capital Advisors, LLC, a registered broker dealer), a boutique
merchant bank also based in Los Angeles.
Mr. Boystak is a founder or director of several life science industry
firms including Exosome Diagnostics, Bruin Biometrics, Bessor /
Brightwaters Pharma, GenoSpace, TrendShift, InSight Health Corp,
PapiVax, and Medical eXcellence (MedX). He also serves on the Health
Advisory Board at The Johns Hopkins Bloomberg School of Public Health
(where he Chairs the Committee for Innovation & Commercialization), and
is a member of the UCLA Foundation Board of Governors.
Previously, Mr. Boystak spent more than 25 years as a senior investment
banker with several major Wall Street firms specializing in life
sciences and health care. He served as founding Managing Director of the
Global Life Science Group at Jefferies & Co., as well as Global Head of
Health Care at Tucker Anthony Sutro and Security Pacific Merchant Bank,
and Vice President of Dean Witter Reynolds.
Mr. Boystak earned a BA from Boston University and a Master of Health
Science degree from The Johns Hopkins Bloomberg School of Public Health.
"Joe's passion for innovation, drive to support entrepreneurship, and
unwavering commitment to grow the bioscience industry in our region make
him a very valuable addition to our board," said SoCalBio President &
CEO Ahmed Enany. "He exemplifies SoCalBio's core values, and we're
thrilled to have an opportunity to work with him closely on
strengthening the L.A. region's healthcare investing eco-system."
About the Southern California Biomedical Council (SoCalBio):
SoCalBio is a nonprofit, member-supported trade association that
promotes life-science research, development, manufacturing, job creation
and overall economic growth in the six counties of the Greater Los
Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside
and San Bernardino). The Council's programs help local firms gain access
to capital, potential partners and business support services. The annual
SoCalBio Investor & Partnership Conference has grown to become the
region's premiere showcase for emerging life-science companies and
technologies. SoCalBio also promotes technology transfer and workforce
training, while informing policy makers and the public at-large about
the benefits of the region's life-science industry. SoCalBio is open to
membership by firms and organizations engaged in life-science technology
development and commercialization. More information is available at www.socalbio.org.
[ Back To NFVZone's Homepage ]